Schedule 13G ownership disclosure

Bellevue Life Sciences Acquisition Corp.

Security class unavailable

Event date: 2023-02-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
400,000
Percent of class
6.6700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001846718-23-000054
Form type
SC 13G
Filer
OSR Holdings, Inc.
CIK
CIK 1840425
Filed
Feb 16, 2023
Reporting period
Feb 10, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub